Search PubMed⌕ Search

Biomedical subjects

Val M Runge

Publications and source records attributed to Val M Runge.

At least 19 recordsLinked to original sources
PubMed2007

Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).

OBJECTIVES: Nephrogenic systemic fibrosis (NSF) is a rare acquired disorder that was first recognized in 1997. Presented is a retrospective review of 6 cases of NSF diagnosed by skin biopsy in our institution during the past 4 years and their relationship to gadodiamide exposure. METHODS AND RESULTS: Patient age ranged from 23 to 71 years. The onset of symptoms consistent with NSF was between 19 days and 2 months after gadodiamide exposure. Five patients had severe renal impairment and started dialysis around the period of gadodiamide exposure (1 day before the 37 days after contrast administration). The sixth patient had a clotted access at the time of a contrast-enhanced magnetic resonance venogram and was hence not being adequately dialyzed. The dose of gadodiamide ranged from 16 to 40 mL (0.11 to 0.36 mmol/kg). Despite having normal serum bicarbonate, 5 of the 6 patients had an elevated anion gap metabolic acidosis. CONCLUSIONS: In our 6 patients, all had either failing native or transplant kidneys at the time of gadodiamide exposure. The development of NSF was temporally related to gadodiamide injection, suggesting as the etiology dechelation of the agent and thus emphasizing the need for change in clinical practice.

Adult↗
PubMed2006

Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.

PURPOSE: To prospectively compare gadobenate dimeglumine with gadopentetate dimeglumine (0.1 mmol per kilogram body weight) for enhanced magnetic resonance (MR) imaging of central nervous system (CNS) lesions. MATERIALS AND METHODS: This study was HIPAA-compliant at U.S. centers and was conducted at all centers according to the Good Clinical Practice standard. Institutional review board and regulatory approval were granted; written informed consent was obtained. Seventy-nine men and 78 women (mean age, 50.5 years +/- 14.4 [standard deviation]) were randomized to group A (n = 78) or B (n = 79). Patients underwent two temporally separated 1.5-T MR imaging examinations. In randomized order, gadobenate followed by gadopentetate was administered in group A; order of administration was reversed in group B. Contrast agent administration (volume, speed of injection), imaging parameters before and after injection, and time between injections and postinjection acquisitions were identical for both examinations. Three blinded neuroradiologists evaluated images by using objective image interpretation criteria for diagnostic information end points (lesion border delineation, definition of disease extent, visualization of internal morphologic features of the lesion, enhancement of the lesion) and quantitative parameters (percentage of lesion enhancement, contrast-to-noise ratio [CNR]). Overall diagnostic preference in terms of lesion conspicuity, detectability, and diagnostic confidence was assessed. Between-group comparisons were performed with Wilcoxon signed rank test. RESULTS: Readers 1, 2, and 3 demonstrated overall preference for gadobenate in 75, 89, and 103 patients, compared with that for gadopentetate in seven, 10, and six patients, respectively (P < .0001). Significant (P < .0001) preference for gadobenate was demonstrated for diagnostic information end points, percentage of lesion enhancement, and CNR. Superiority of gadobenate was significant (P < .001) in patients with intraaxial and extraaxial lesions. CONCLUSION: Gadobenate compared with gadopentetate at an equivalent dose provides significantly better enhancement and diagnostic information for CNS MR imaging.

Central Nervous System Diseases↗
PubMed2006

Dual breath-hold magnetic resonance cine evaluation of global and regional cardiac function.

The purpose of our study was to evaluate the accuracy of a multislice cine magnetic resonance imaging (MRI) technique with parallel imaging in regard to global and regional left ventricular function. Forty-two individuals underwent cine MRI on a 1.5-tesla scanner. Cine MRI used a steady-state free precession technique and was performed as a single-slice technique (nonTSENSE cine) and an accelerated multislice technique (TSENSE cine) with five slices per breath-hold. End diastolic volume (EDV), end systolic volume (ESV), and ejection fraction (EF) were evaluated for all data sets and in regard to regional wall motion and regional wall motion analysis, and quantitative regional wall thickness and systolic thickening were also assessed. EDV, ESV, and EF based on TSENSE cine showed excellent correlation to the nonTSENSE cine approach (all r(2)=0.99, P<0.001). While EDV evaluations showed a small underestimation for TSENSE cine, ESV and EF showed accurate results compared with nonTSENSE cine. Both readers showed good agreement (kappa=0.72) in regional wall motion assessment comparing both techniques. Data acquisition for the multislice approach was significantly shorter ( approximately 75%) that in single-slice cine. We conclude that accurate evaluation of regional wall motion and left ventricular EF is possible using accelerated multislice cine MR with high spatial and temporal resolution.

Adolescent↗
PubMed2006

Renal arteries: comparison of steady-state free precession MR angiography and contrast-enhanced MR angiography.

All participants provided informed consent to participate in this study, which was approved by the institutional review board. Breath-hold three-dimensional (3D) steady-state free precession (SSFP) magnetic resonance (MR) angiography was compared with 3D contrast material-enhanced MR angiography in patients suspected of having renal artery stenosis. Two radiologists assessed visualization of renal arteries and detection of vascular disease. With SSFP MR angiography, 39 of 41 renal arteries in 19 patients were correctly detected. Relevant stenoses were correctly identified with SSFP MR angiography in two patients. In two patients, SSFP MR angiographic data sets led to false-positive overgrading of vascular disease. Fast breath-hold 3D SSFP MR angiography appears to be feasible for MR angiography of renal arteries.

Adolescent↗
PubMed2006

Analysis of ischemic stroke MR images by means of brain atlases of anatomy and blood supply territories.

RATIONALE AND OBJECTIVES: A method for atlas-assisted analysis of stroke magnetic resonance images that is a part of a stroke computer-assisted diagnosis system supporting rapid and quantitative checking of thrombolysis conditions is presented. MATERIALS AND METHODS: Two brain atlases are used for analysis: atlas of anatomy (AA) and atlas of blood supply territories (BSTs). To map these atlases onto scans, two methods are used at present: (1) fast Talairach transformation and (2) midsagittal plane and brain's bounding box matching. After atlas-to-scan mapping, both atlases are superimposed onto the studied images and can be used to get their underlying anatomy and BSTs. To speed up the process of analysis, the system automatically analyzes entire regions occupied by the infarct and penumbra. RESULTS: By using both atlases, the system calculates the following values for each infarct and penumbra region: (1) names of all anatomic structures and BSTs within the region, (2) volumes of occupancy for each structure and territory, and (3) percentages of occupancy for each structure and territory. In addition, the system calculates the infarct-middle cerebral artery (MCA) territory ratio for diffusion-weighted images and the penumbra-MCA territory ratio for perfusion images. Atlas-assisted analysis is fast, and calculations take less than 10 seconds. CONCLUSION: This method potentially facilitates and speeds up stroke data analysis, as well as supports decision making.

Atlases as Topic↗
PubMed2006

Magnetic resonance imaging of the levator ani in the squirrel monkey: a comparison of muscle volume between a cohort with pelvic organ prolapse and matched normals.

OBJECTIVE: Magnetic resonance imaging was used to test whether squirrel monkeys with pelvic organ prolapse have reduced pelvic muscle volumes, compared with matched normals. STUDY DESIGN: Levator ani and obturator internus volumes obtained from T1-weighted axial scans of matched groups were measured. Muscle volumes and weights were compared for animals necropsied after magnetic resonance imaging. RESULTS: Two observers concurred on measures of levator ani and obturator internus (Kendal tau > or = 0.60 with P < .003). Levator ani volume was related to mass (R2 = 0.62, P = .0009). Animals with pelvic organ prolapse did not differ (P = .67, Wilks multivariate test) from those without pelvic organ prolapse in age, parity, and weight. Levator ani differed between groups (pelvic organ prolapse = 520 mm3 versus normals = 392 mm3, P = .015) and not sides (P = .80). The obturator internus did not differ between groups (P = .29) or sides (P = .72). CONCLUSION: Magnetic resonance imaging demonstrates that levator ani volumes in parous squirrel monkeys with pelvic organ prolapse were not reduced, suggesting that prolapse is not related to pelvic muscle size reduction in this species.

Abdominal Muscles↗
PubMed2006

Advances in clinical 3-tesla neuroimaging.

Three-tesla magnetic resonance (MR) imaging represents one of the major forefronts of diagnostic neuroradiology today. Heat deposition, changes in T1 relaxation rates, susceptibility differences, and greater inherent sensitivity to motion artifacts represent challenges to clinical implementation. However, the situation appears remarkably similar to that encountered almost 15 years ago as the field of MR transitioned from 0.3-0.6 T to 1.5 T units. Current-generation 3 T MR units already provide markedly improved imaging of the brain as compared with 1.5 T units. This is illustrated in the article that follows, together with many of the advanced techniques now available and in the pipeline to deal with the difficulties inherent at 3 T.

Adult↗
PubMed2006

The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.

OBJECTIVES: The objectives of this study were to analyze the differences in contrast enhancement using gadobenate dimeglumine (Gd-BOPTA or MultiHance) at 3 T versus 1.5 T and to compare Gd-BOPTA with a standard gadolinium chelate, gadopentetate dimeglumine (Gd-DTPA or Magnevist), at 3 T in a rat glioma model. MATERIALS AND METHODS: Twelve rats with surgically implanted gliomas were randomized to either comparing Gd-BOPTA at 1.5 T versus 3 T (n=7) or comparing Gd-BOPTA and Gd-DTPA at 3 T (n=5). Matched T1-weighted spin-echo techniques were used for both comparisons and the order of examinations was randomized. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and lesion enhancement (LE) were evaluated using a region-of-interest analysis. A veterinary histopathologist evaluated all brain specimens. RESULTS: In the evaluation of Gd-BOPTA at 3 T and 1.5 T, there were significant increases in SNR, LE, and CNR at 3 T. Average increases in brain and tumor SNR were 93% (P<0.0001) and 92% (P<0.0001), respectively. CNR increased by 121% (P<0.0001). Comparison of Gd-BOPTA and Gd-DTPA at 3 T demonstrated significantly higher CNR and LE with Gd-BOPTA. CNR increased by 35% (P=0.002). LE increased by 44% (P=0.03). CONCLUSIONS: Gd-BOPTA provides significantly higher CNR at 3 T compared with 1.5 T and also demonstrates significantly higher CNR when compared with a standard Gd-chelate at 3 T. As a result of transient protein binding, Gd-BOPTA may be superior to standard gadolinium chelates in neurologic imaging at 3 T.

Animals↗
PubMed2006

T1-weighted imaging of the brain at 3 tesla using a 2-dimensional spoiled gradient echo technique.

RATIONALE AND OBJECTIVES: The objective of this study was to evaluate a 2-dimensional spoiled gradient echo (GRE) imaging approach using a very short in-phase TE for routine T1-weighted imaging of the brain at 3 T. MATERIALS AND METHODS: Patient examinations were compared from a 3 T magnetic resonance (MR) unit located immediately adjacent to a similarly equipped 1.5 T unit. Pre- and postcontrast T1-weighted images were evaluated and compared at 1.5 versus 3 T with a 2-dimensional (2-D) spin echo sequence used at 1.5 T and a 2-D GRE sequence at 3 T. The 2 MR systems used are from the same vendor, use similar 8-channel coils, and use identical gradients. The T1-weighted GRE sequence, used at 3 T, relies on a short TE (2.4 ms) to limit flow-related and susceptibility artifacts. Region-of-interest analysis was performed on 16 different sagittal patient examinations at both field strengths (32 total) and similarly on 10 different pre- and postcontrast axial examinations (40 total). Four blinded neuroradiologists also evaluated these studies. RESULTS: Using an off-midline sagittal slice depicting the caudate nucleus (signal-to-noise ratio [SNR] 163 +/- 28 vs. 70 +/- 7, 3 T vs. 1.5 T) and corona radiata (SNR 214 +/- 35 vs. 82 +/- 10), 3 T markedly outperformed 1.5 T in both SNR and contrast-to-noise ratio (CNR) (51 +/- 14 vs. 12 +/- 5). On axial imaging, despite a reduction in slice thickness (5 to 3 mm) and scan time (5 to 1 minute), there was no significant difference pre- or postcontrast in SNR and CNR comparing 3 and 1.5 T. On blinded film review, 3 T performed slightly better on sagittal scans than 1.5 T in regard to motion artifacts (reduced), gray-white matter differentiation, and overall image quality. On axial scans, 3 T performed markedly better in all 3 categories both pre- and postcontrast. In regard to overall image quality, 3 T was preferred 9:2 precontrast and 4:1 postcontrast. CONCLUSIONS: High-quality, thin-section (3-mm) T1-weighted imaging can be readily performed at 3 T using a short TE 2-D GRE technique. This approach offers superior SNR and CNR with reduced motion artifacts and scan time as compared with imaging at 1.5 T and is advocated for routine brain imaging at 3 T. It is robust (used in over 1500 patients to date) and does not experience significant specific absorption ratio limitations, poor tissue contrast, or accentuated motion artifacts like encountered with spin echo T1-weighted imaging at 3 T.

Adult↗
PubMed2006

Brain magnetic resonance imaging at 3 Tesla using BLADE compared with standard rectilinear data sampling.

OBJECTIVES: We sought to evaluate Periodically Rotated Overlapping ParallEL Lines with Enhanced Reconstruction (PROPELLER; BLADE) data acquisition in comparison with standard k-space sampling techniques for axial and sagittal brain imaging at 3 T regarding imaging artifacts. MATERIAL AND METHODS: Forty patients who gave consent were included in a prospective comparison of standard and PROPELLER (BLADE) k-space sampling techniques. All examinations were performed at 3 T with comparison of standard T2-weighted fluid-attenuated inversion recovery (FLAIR) to PROPELLER T2-weighted FLAIR in the axial image orientation and standard T1-weighted gradient echo to PROPELLER T1-weighted FLAIR in the sagittal image orientation. Imaging protocols were matched for spatial resolution, with data evaluation performed by 2 experienced neuroradiologists. Image data were compared regarding various image artifacts and overall image quality. Reader agreement was assessed by Cohen's kappa statistics. RESULTS: PROPELLER T2-weighted axial data acquisition showed significantly less pulsation and Gibb's artifacts than the standard T2-weighted scan. Even without motion correction, the frequency of ghosting (motion) artifacts was substantially lower in the PROPELLER T2-weighted data and readers concordantly (kappa = 1) rated PROPELLER as better than or equal to the standard T2-weighted scan in the majority of cases (95%; P < 0.0001). In the comparison of sagittal T1-weighted data sets, readers showed only fair agreement (kappa = 0.24) and noted consistent wrap artifacts in PROPELLER T1-weighted FLAIR. CONCLUSION: PROPELLER (BLADE) brain magnetic resonance imaging is also applicable at 3 T. In addition to minimizing motion artifacts, the PROPELLER acquisition scheme reduces other magnetic resonance artifacts that would otherwise degrade scan quality.

Adult↗
PubMed2006

Advances in magnetic resonance (2006).

Advances in the field of magnetic resonance (MR) as it pertains to clinical diagnostic radiology are examined in this review on the basis of publications in Investigative Radiology over the past 2 years (2005-2006). The articles published during that timeframe are discussed, organizationally wise, by anatomic region with an additional focus on studies involving MR contrast media.

Brain↗
PubMed2005

Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla.

OBJECTIVE: The objective of this study was to compare the difference in lesion enhancement between 1.5 and 3 T using an extracellular gadolinium chelate in a rat brain glioma model. METHODS: Five rats (CDF Fischer 344) with implanted C6/LacZ brain gliomas were evaluated using matched T1-weighted spin echo techniques and hardware configurations at 1.5 and 3 T. Serial imaging over 10 minutes after gadoteridol (ProHance) administration was performed. Contrast enhancement (CE), signal-to-noise ratios (SNR) for brain and tumor, as well as contrast-to-noise ratios (CNR) were evaluated using region-of-interest (ROI) analysis at both field strengths. All gliomas were also evaluated by histopathology. RESULTS: CE at 3 T increased by 106% to 137% (all P<0.05) with maximum CE occurring at 5 minutes for both 1.5 and 3 T (9.8+/-2.2 vs 21.1+/-3.5; P=0.0004). At 3 T, SNR increased for normal brain by 66% to 76% (P<0.01) and SNR for tumor increased by 70% to 89% (P<0.01). CNR increased by 101% to 137% (P<0.05) depending on the time postcontrast. The highest CNR for both 1.5 T and 3 T occurred 5 minutes after contrast (1.5 T: 9.4+/-1.1 vs 3 T: 20.3+/-2.4; P<0.0004). CONCLUSION: Using a standardized animal model and matched scan techniques, this study shows a significant benefit of 3 T compared with 1.5 T in contrast-enhanced brain tumor magnetic resonance imaging.

Animals↗
PubMed2004

Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.

PURPOSE: To evaluate the safety of and compare the enhancement characteristics of gadobenate dimeglumine (MultiHance; Bracco Imaging, Milan, Italy) with those of a standard gadolinium chelate (gadopentetate dimeglumine, Magnevist; Schering, Berlin, Germany) in primary and secondary brain tumors on the basis of qualitative and quantitative parameters, on an intraindiviual basis. MATERIALS AND METHODS: Twenty-seven patients with either high-grade glioma or metastases were enrolled in a bicentric intraindividual crossover study to compare lesion enhancement with doses of 0.1 mmol per kilogram of body weight of 0.5 mol/L gadopentetate dimeglumine and 0.5 mol/L gadobenate dimeglumine. MR imaging was performed before injection (T1-weighted spin-echo [SE] and T2-weighted fast SE acquisitions) and at 1, 3, 5, 7, 9, and 16 minutes after injection (T1-weighted SE acquisitions). Qualitative assessment was performed by blinded off-site readers (for 22 patients) and on-site investigators (for 24 patients) in terms of global contrast enhancement, lesion-to-brain contrast, lesion delineation, internal lesion morphology and structure, tumor vascularization, and global image preference. Additional quantitative assessment with region-of-interest analysis was performed by off-site readers alone. Statistical analysis of qualitative data was performed with the Wilcoxon signed rank test, whereas a nonparametric approach was adopted for analysis of quantitative data. RESULTS: Significant (P <.05) preference for gadobenate dimeglumine over gadopentetate dimeglumine was noted both off-site and on-site for the global assessment of contrast enhancement. For off-site readers 1 and 2 and the on-site investigators, respectively, gadobenate dimeglumine was preferred in 13, 17, and 16 patients; gadopentetate dimeglumine was preferred in four, four, and four patients; and equality was found in five, one, and four patients). Similar preference for gadobenate dimeglumine was noted by off-site readers and on-site investigators for lesion-to-brain contrast and all other qualitative parameters. Off-site quantitative evaluation revealed significantly (P <.05) superior enhancement for gadobenate dimeglumine compared with that for gadopentetate dimeglumine at all time points from 3 minutes after injection. CONCLUSION: Significantly superior contrast enhancement of intraaxial enhancing brain tumors was achieved with 0.1 mmol/kg gadobenate dimeglumine compared with that with 0.1 mmol/kg gadopentetate dimeglumine.

Adult↗
PubMed2003

Contrast use at low field: a review.

The use of gadolinium-based contrast agents for magnetic resonance imaging at low fields (</=0.5 T) is reviewed. Magnetic resonance studies on low-field units represent an important subset of examinations performed in the United States. Although many fundamental principles of contrast usage apply both to high-field and low-field examinations, contrast enhancement is field dependent. Although diagnostic yield is not equivalent at all field strengths, contrast effect on low-field examinations at double doses (0.2 mmol/kg) of intravenous contrast approaches that on high-field (1.5 T) examinations at standard dose (0.1 mmol/kg). It is recommended that radiologists operating low-field units routinely employ what would otherwise be considered a double dose of a gadolinium chelate for neuroradiologic examinations.

Brain Neoplasms↗
PubMed2003

Contrast agents for magnetic resonance imaging: safety update.

Magnetic resonance contrast agents, particularly the gadolinium-based agents, are extremely safe and lack the nephrotoxicity associated with iodinated contrast media. Currently, seven gadolinium agents are available in one or more countries of the world, of which only four are available for clinical use in the United States. Minor adverse effects associated with each of these agents occur infrequently and include nausea, headache, and taste perversion. Whereas the gadolinium agents cannot be differentiated on the basis of these mild adverse effects, recent studies have brought to light the issue of chelate stability, and in particular, clinical observations associated with the least stable of these agents. This review briefly discusses the most recent safety issues concerning the gadolinium agents. A brief review of safety issues concerning the non-gadolinium agents is also provided.

Contrast Media↗